vs
MAGNITE, INC.（MGNI）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是MAGNITE, INC.的1.0倍（$207.3M vs $205.4M），MAGNITE, INC.净利率更高（59.9% vs -62.0%，领先121.9%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 5.9%），MAGNITE, INC.自由现金流更多（$103.1M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 17.3%）
Magnite是总部位于美国加利福尼亚州洛杉矶的在线广告技术企业，由Rubicon Project与Telaria于2020年合并成立，专注于广告技术领域的相关业务，为行业提供数字化广告技术解决方案。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
MGNI vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $205.4M | $207.3M |
| 净利润 | $123.0M | $-128.6M |
| 毛利率 | 66.2% | — |
| 营业利润率 | 25.3% | -54.7% |
| 净利率 | 59.9% | -62.0% |
| 营收同比 | 5.9% | 25.9% |
| 净利润同比 | 238.0% | 3.5% |
| 每股收益（稀释后） | $0.81 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $205.4M | $207.3M | ||
| Q3 25 | $179.5M | $159.9M | ||
| Q2 25 | $173.3M | $166.5M | ||
| Q1 25 | $155.8M | $139.3M | ||
| Q4 24 | $194.0M | $164.6M | ||
| Q3 24 | $162.0M | $139.5M | ||
| Q2 24 | $162.9M | $147.0M | ||
| Q1 24 | $149.3M | $108.8M |
| Q4 25 | $123.0M | $-128.6M | ||
| Q3 25 | $20.1M | $-180.4M | ||
| Q2 25 | $11.1M | $-115.0M | ||
| Q1 25 | $-9.6M | $-151.1M | ||
| Q4 24 | $36.4M | $-133.2M | ||
| Q3 24 | $5.2M | $-133.5M | ||
| Q2 24 | $-1.1M | $-131.6M | ||
| Q1 24 | $-17.8M | $-170.7M |
| Q4 25 | 66.2% | — | ||
| Q3 25 | 61.4% | — | ||
| Q2 25 | 62.5% | — | ||
| Q1 25 | 59.7% | — | ||
| Q4 24 | 65.1% | — | ||
| Q3 24 | 61.4% | — | ||
| Q2 24 | 61.6% | — | ||
| Q1 24 | 55.9% | — |
| Q4 25 | 25.3% | -54.7% | ||
| Q3 25 | 14.0% | -106.9% | ||
| Q2 25 | 12.7% | -64.8% | ||
| Q1 25 | -0.9% | -102.6% | ||
| Q4 24 | 20.7% | -74.3% | ||
| Q3 24 | 9.3% | -94.6% | ||
| Q2 24 | 5.9% | -79.1% | ||
| Q1 24 | -9.3% | -151.9% |
| Q4 25 | 59.9% | -62.0% | ||
| Q3 25 | 11.2% | -112.8% | ||
| Q2 25 | 6.4% | -69.0% | ||
| Q1 25 | -6.2% | -108.5% | ||
| Q4 24 | 18.8% | -80.9% | ||
| Q3 24 | 3.2% | -95.7% | ||
| Q2 24 | -0.7% | -89.5% | ||
| Q1 24 | -11.9% | -156.8% |
| Q4 25 | $0.81 | $-1.28 | ||
| Q3 25 | $0.13 | $-1.81 | ||
| Q2 25 | $0.08 | $-1.17 | ||
| Q1 25 | $-0.07 | $-1.57 | ||
| Q4 24 | $0.26 | $-1.34 | ||
| Q3 24 | $0.04 | $-1.40 | ||
| Q2 24 | $-0.01 | $-1.52 | ||
| Q1 24 | $-0.13 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $553.4M | $421.0M |
| 总债务越低越好 | $556.1M | — |
| 股东权益账面价值 | $922.4M | $-80.0M |
| 总资产 | $3.2B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.60× | — |
8季度趋势，按日历期对齐
| Q4 25 | $553.4M | $421.0M | ||
| Q3 25 | $482.1M | $202.5M | ||
| Q2 25 | $426.0M | $176.3M | ||
| Q1 25 | $429.7M | $127.1M | ||
| Q4 24 | $483.2M | $174.0M | ||
| Q3 24 | $387.2M | $150.6M | ||
| Q2 24 | $326.5M | $480.7M | ||
| Q1 24 | $252.8M | $112.3M |
| Q4 25 | $556.1M | — | ||
| Q3 25 | $556.3M | — | ||
| Q2 25 | $556.4M | — | ||
| Q1 25 | $556.6M | — | ||
| Q4 24 | $553.7M | — | ||
| Q3 24 | $553.8M | — | ||
| Q2 24 | $552.7M | — | ||
| Q1 24 | $552.7M | — |
| Q4 25 | $922.4M | $-80.0M | ||
| Q3 25 | $808.0M | $9.2M | ||
| Q2 25 | $768.5M | $151.3M | ||
| Q1 25 | $741.8M | $144.2M | ||
| Q4 24 | $768.2M | $255.0M | ||
| Q3 24 | $725.9M | $346.8M | ||
| Q2 24 | $713.0M | $432.4M | ||
| Q1 24 | $695.4M | $140.3M |
| Q4 25 | $3.2B | $1.5B | ||
| Q3 25 | $2.9B | $1.2B | ||
| Q2 25 | $2.9B | $1.3B | ||
| Q1 25 | $2.7B | $1.3B | ||
| Q4 24 | $2.9B | $1.5B | ||
| Q3 24 | $2.7B | $1.5B | ||
| Q2 24 | $2.6B | $1.6B | ||
| Q1 24 | $2.5B | $1.3B |
| Q4 25 | 0.60× | — | ||
| Q3 25 | 0.69× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.72× | — | ||
| Q3 24 | 0.76× | — | ||
| Q2 24 | 0.78× | — | ||
| Q1 24 | 0.79× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $128.5M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $103.1M | $-100.8M |
| 自由现金流率自由现金流/营收 | 50.2% | -48.6% |
| 资本支出强度资本支出/营收 | 12.4% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.04× | — |
| 过去12个月自由现金流最近4个季度 | $165.6M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $128.5M | $-99.8M | ||
| Q3 25 | $86.6M | $-91.4M | ||
| Q2 25 | $18.5M | $-108.3M | ||
| Q1 25 | $2.6M | $-166.5M | ||
| Q4 24 | $114.7M | $-79.3M | ||
| Q3 24 | $91.3M | $-67.0M | ||
| Q2 24 | $89.6M | $-77.0M | ||
| Q1 24 | $-60.4M | $-190.7M |
| Q4 25 | $103.1M | $-100.8M | ||
| Q3 25 | $68.4M | $-92.7M | ||
| Q2 25 | $6.0M | $-110.7M | ||
| Q1 25 | $-11.8M | $-167.8M | ||
| Q4 24 | $111.0M | $-79.5M | ||
| Q3 24 | $77.3M | $-68.6M | ||
| Q2 24 | $80.4M | $-79.0M | ||
| Q1 24 | $-66.3M | $-193.9M |
| Q4 25 | 50.2% | -48.6% | ||
| Q3 25 | 38.1% | -58.0% | ||
| Q2 25 | 3.5% | -66.5% | ||
| Q1 25 | -7.6% | -120.5% | ||
| Q4 24 | 57.2% | -48.3% | ||
| Q3 24 | 47.7% | -49.2% | ||
| Q2 24 | 49.4% | -53.7% | ||
| Q1 24 | -44.4% | -178.2% |
| Q4 25 | 12.4% | 0.5% | ||
| Q3 25 | 10.2% | 0.8% | ||
| Q2 25 | 7.2% | 1.5% | ||
| Q1 25 | 9.2% | 1.0% | ||
| Q4 24 | 1.9% | 0.1% | ||
| Q3 24 | 8.7% | 1.2% | ||
| Q2 24 | 5.6% | 1.4% | ||
| Q1 24 | 3.9% | 3.0% |
| Q4 25 | 1.04× | — | ||
| Q3 25 | 4.32× | — | ||
| Q2 25 | 1.66× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.15× | — | ||
| Q3 24 | 17.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MGNI
| Connected Television | $103.4M | 50% |
| Other | $55.7M | 27% |
| Desktop | $28.9M | 14% |
| Gross Revenue | $17.4M | 8% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
